SMAD2 and polycystic ovary syndrome: Treatment with either Rha or Met significantly reduced the pixel-based intensity of TGF-β1, Smad2, Smad3, and Smad4 with a significant increase in the pixel-based intensity of Smad7 expression compared to that of the PCOS group (P < 0.01).